This statistic shows the percentage of U.S. adults with cancer that had discussed select treatment options with their doctor for the management of their cancer symptoms in 2020. According to the survey, in 2020, around 19 percent of respondents had discussed prescription opioid use with their doctor.
Percentage of U.S. adults with cancer that had ever discussed select treatments for symptom management with their doctor in 2020
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Predicted decrease in select illnesses due to cannabis legalization Canada 2018
- Basic Statistic Percentage of Canadian doctors that supported cannabis legalization June 2018
- Basic Statistic Predicted increase in select illnesses due to cannabis legalization in Canada 2018
- Basic Statistic Physician opinions on recreational vs. medical cannabis Canada June 2018
- Basic Statistic Number of abortions in Canada in 2022, by provider and territory
- Premium Statistic Surface disinfectant revenue in Latin America 2022-2027
- Premium Statistic Primary care physician needs among U.S. adults in 2019, by generation
- Premium Statistic Lifetime prevalence of ED visits among U.S. adults with food allergies 2016, by food
- Premium Statistic 12-month prevalence of ED visits among U.S. adults with food allergies 2016, by food
- Basic Statistic Gynecologist and obstetrician industry market size in the U.S. from 2010 to 2020
About the region
10
- Basic Statistic Cancer treatments used by U.S. adults with cancer experience last 12 months 2019
- Basic Statistic Opinions on alternative medicine use for cancer treatment in the U.S. in 2018, by age
- Basic Statistic Support for medical marijuana legalization by cancer experience 2020
- Basic Statistic Support for medical marijuana legalization for select uses 2018, by age
- Basic Statistic Prescription opioid/marijuana access difficulty among U.S. cancer patients 2019
- Basic Statistic Medical marijuana efficacy for managing symptoms among U.S. cancer patients 2019
- Basic Statistic Opinions on opioid policies for U.S. cancer patients 2019, by political affiliation
- Basic Statistic Opinions on alternative treatments for cancer U.S. 2019, by political affiliation
- Basic Statistic Anxiety among U.S. cancer patients regarding their financial situation 2019
- Basic Statistic U.S. opinions on decriminalization of marijuana as of 2018, by political views
Other regions
10
- Basic Statistic Quarterly medical cannabis oil products sold in Canada 2016-2019
- Basic Statistic U.S. medical cannabis patient-selected most important benefits as of 2017
- Basic Statistic Attitudes towards Ebola survivors in Guinea as of 2015
- Premium Statistic Quarterly wholesale price of a pound of marijuana in Nevada 2017-2018
- Premium Statistic UK: opinion on the effectiveness of vaccines to prevent infectious diseases in 2019
- Premium Statistic Bulgaria: opinion on effectiveness of vaccines to prevent infectious diseases 2019
- Premium Statistic Romania: opinion on effectiveness of vaccines to prevent infectious diseases 2019
- Premium Statistic Slovakia: opinion on the effectiveness of vaccines to prevent diseases 2019
- Premium Statistic Estonia: opinion on the effectiveness of vaccines to prevent infectious diseases
- Premium Statistic Greece: opinion on the effectiveness of vaccines to prevent infectious diseases
Related statistics
10
- Basic Statistic Share of French people who declare avoiding social gatherings 2021, by age
- Basic Statistic Popular opinion on reasons for coronavirus outbreak in France 2020
- Basic Statistic Opinions on measures taken to control the spread of coronavirus in France in 2020
- Basic Statistic Opinion of French people on the level of threat that the coronavirus represents 2020
- Basic Statistic Level of threat that the coronavirus represents personally in France in 2020
- Basic Statistic Level of threat that the coronavirus represents to families in France in 2020
- Basic Statistic Confidence in institutions to handle the coronavirus outbreak in France in 2020
- Basic Statistic Level of threat that the coronavirus represents in France in 2020
- Basic Statistic Confidence in media concerning the coronavirus outbreak in France in 2020
- Basic Statistic Coronavirus worldwide threat level according to French people in 2020
Further related statistics
10
- MorphoSys' research & development expenditure 2006-2023
- Leading causes of death among Black U.S. residents in 2020
- Leading causes of death among the white population in the United States in 2020
- Number of cannabis users worldwide by region 2011-2021
- Sexually experienced U.S. woman with partner using a condom or withdrawal 1982-2010
- Focus areas of U.S. employer's health care strategies 2013
- AstraZeneca's expenditure on research and development 2006-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
Further Content: You might find this interesting as well
Statistics
- MorphoSys' research & development expenditure 2006-2023
- Leading causes of death among Black U.S. residents in 2020
- Leading causes of death among the white population in the United States in 2020
- Number of cannabis users worldwide by region 2011-2021
- Sexually experienced U.S. woman with partner using a condom or withdrawal 1982-2010
- Focus areas of U.S. employer's health care strategies 2013
- AstraZeneca's expenditure on research and development 2006-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
American Society of Clinical Oncology. (October 1, 2020). Percentage of U.S. adults with cancer that had ever discussed select treatments for symptom management with their doctor in 2020 [Graph]. In Statista. Retrieved April 23, 2024, from https://www.statista.com/statistics/944619/cancer-symptom-management-us-cancer-patients/
American Society of Clinical Oncology. "Percentage of U.S. adults with cancer that had ever discussed select treatments for symptom management with their doctor in 2020." Chart. October 1, 2020. Statista. Accessed April 23, 2024. https://www.statista.com/statistics/944619/cancer-symptom-management-us-cancer-patients/
American Society of Clinical Oncology. (2020). Percentage of U.S. adults with cancer that had ever discussed select treatments for symptom management with their doctor in 2020. Statista. Statista Inc.. Accessed: April 23, 2024. https://www.statista.com/statistics/944619/cancer-symptom-management-us-cancer-patients/
American Society of Clinical Oncology. "Percentage of U.S. Adults with Cancer That Had Ever Discussed Select Treatments for Symptom Management with Their Doctor in 2020." Statista, Statista Inc., 1 Oct 2020, https://www.statista.com/statistics/944619/cancer-symptom-management-us-cancer-patients/
American Society of Clinical Oncology, Percentage of U.S. adults with cancer that had ever discussed select treatments for symptom management with their doctor in 2020 Statista, https://www.statista.com/statistics/944619/cancer-symptom-management-us-cancer-patients/ (last visited April 23, 2024)
Percentage of U.S. adults with cancer that had ever discussed select treatments for symptom management with their doctor in 2020 [Graph], American Society of Clinical Oncology, October 1, 2020. [Online]. Available: https://www.statista.com/statistics/944619/cancer-symptom-management-us-cancer-patients/